AU562807B2 - Tetrapeptides - Google Patents

Tetrapeptides

Info

Publication number
AU562807B2
AU562807B2 AU45666/85A AU4566685A AU562807B2 AU 562807 B2 AU562807 B2 AU 562807B2 AU 45666/85 A AU45666/85 A AU 45666/85A AU 4566685 A AU4566685 A AU 4566685A AU 562807 B2 AU562807 B2 AU 562807B2
Authority
AU
Australia
Prior art keywords
tetrapeptides
sub
sar
tyr
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU45666/85A
Other languages
English (en)
Other versions
AU4566685A (en
Inventor
George Heavner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22576099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU562807(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of AU4566685A publication Critical patent/AU4566685A/en
Application granted granted Critical
Publication of AU562807B2 publication Critical patent/AU562807B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Compounds Of Unknown Constitution (AREA)
AU45666/85A 1980-06-17 1985-07-31 Tetrapeptides Ceased AU562807B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/160,241 US4298523A (en) 1980-06-17 1980-06-17 Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
US160241 1980-06-17

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU70980/81A Division AU547212B2 (en) 1980-06-17 1981-05-25 Peptides

Publications (2)

Publication Number Publication Date
AU4566685A AU4566685A (en) 1985-11-07
AU562807B2 true AU562807B2 (en) 1987-06-18

Family

ID=22576099

Family Applications (3)

Application Number Title Priority Date Filing Date
AU45666/85A Ceased AU562807B2 (en) 1980-06-17 1985-07-31 Tetrapeptides
AU45667/85A Ceased AU562808B2 (en) 1980-06-17 1985-07-31 Tripeptides
AU45668/85A Ceased AU563303B2 (en) 1980-06-17 1985-07-31 Proetected dipeptides

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU45667/85A Ceased AU562808B2 (en) 1980-06-17 1985-07-31 Tripeptides
AU45668/85A Ceased AU563303B2 (en) 1980-06-17 1985-07-31 Proetected dipeptides

Country Status (19)

Country Link
US (1) US4298523A (US06255285-20010703-C00102.png)
EP (3) EP0565148A2 (US06255285-20010703-C00102.png)
JP (3) JPS5728036A (US06255285-20010703-C00102.png)
AT (2) ATE24183T1 (US06255285-20010703-C00102.png)
AU (3) AU562807B2 (US06255285-20010703-C00102.png)
CA (6) CA1188297A (US06255285-20010703-C00102.png)
DE (2) DE3175701D1 (US06255285-20010703-C00102.png)
DK (3) DK151968C (US06255285-20010703-C00102.png)
ES (3) ES503012A0 (US06255285-20010703-C00102.png)
FI (1) FI79329C (US06255285-20010703-C00102.png)
GR (1) GR74546B (US06255285-20010703-C00102.png)
IE (3) IE62213B1 (US06255285-20010703-C00102.png)
IL (7) IL72393A (US06255285-20010703-C00102.png)
NO (3) NO161744C (US06255285-20010703-C00102.png)
NZ (1) NZ197294A (US06255285-20010703-C00102.png)
PH (2) PH16501A (US06255285-20010703-C00102.png)
PT (1) PT73201B (US06255285-20010703-C00102.png)
YU (1) YU45852B (US06255285-20010703-C00102.png)
ZA (1) ZA814061B (US06255285-20010703-C00102.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369137A (en) * 1980-06-17 1983-01-18 Ortho Pharmaceutical Corporation N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DE3401545A1 (de) * 1983-08-03 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue peptide mit immunstimulierender wirkung, verfahren zu deren herstellung und deren verwendung
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
AU602483B2 (en) * 1985-01-18 1990-10-18 Immunetech Pharmaceuticals Immunoregulatory peptides
US4749690A (en) * 1986-01-27 1988-06-07 Ortho Pharmaceutical Corporation Treatment of allergy with thymopentin
US4732970A (en) * 1986-06-13 1988-03-22 American Cyanamid Company Antitumor amino acid and peptide derivatives of 1,4-bis(aminoalkyl and hydroxy-aminoalkyl)amino)-5,8-dihydroxyanthraquinones
US5200506A (en) * 1987-03-19 1993-04-06 Eniricerche S.P.A. Process for preparing new thymopentin retro-inverso analogs and fragments thereof and the intermediates obtained therein
HU199878B (en) * 1987-06-19 1990-03-28 Berlin Chemie Veb Process for producing acylated splenopentynes and pharmaceutical compositions comprising such compounds as active ingredient
US5656601A (en) * 1987-06-19 1997-08-12 Berlin-Chemie Ag Acylated splenopentins, methods for their synthesis and their use
FR2622587B1 (fr) * 1987-10-30 1990-12-21 Inst Vaisseaux Sang Peptide lysyl-arginyl-aspartyl-serine et ses applications en tant que medicament, notamment antithrombotique
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
JPH01264767A (ja) * 1988-11-17 1989-10-23 G N Tool Kk 砥石自動交換ｃｎｃ工具研削盤
CN101168560B (zh) * 2006-10-23 2012-09-05 江苏正大天晴药业股份有限公司 N-取代肽酰胺，其药物组合物与用途
EP2376101B1 (en) 2008-12-29 2015-12-02 Trevena, Inc. Beta-arrestin effectors and compositions and methods of use thereof
JP2017506235A (ja) 2014-02-07 2017-03-02 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． ベータ−アレスチンエフェクターの結晶性および非晶質形態
AU2015264367A1 (en) 2014-05-19 2016-12-15 Trevena, Inc. Synthesis of Beta-Arrestin Effectors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317559A (en) * 1963-08-23 1967-05-02 American Cyanamid Co alpha-amino acid esters of n-hydroxysuccinimide and preparation and use in peptide synthesis
DE1593830A1 (de) * 1967-05-24 1971-03-11 Akad Wissenschaften Ddr Verfahren zur Herstellung von Peptiden
US3560503A (en) * 1968-09-18 1971-02-02 Council Scient Ind Res Di-lower alkyl-substituted octahydropyrazinopyrimidinones
JPS4826010B1 (US06255285-20010703-C00102.png) * 1969-11-11 1973-08-03
US3997516A (en) * 1974-07-04 1976-12-14 Takeda Chemical Industries, Ltd. Method for protecting guanidino group and restoring the same
DE2544348C3 (de) * 1975-10-03 1979-12-13 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L-Leucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
SE446867B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
CA1156220A (en) * 1979-04-26 1983-11-01 George Heavner Method and composition for preparation of h-sar-lys-sar-gln-nh.sub.2
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4309340A (en) * 1980-03-31 1982-01-05 American Home Products Corporation Polypeptide compositions

Also Published As

Publication number Publication date
DK415485D0 (da) 1985-09-12
ES8303298A1 (es) 1983-02-01
AU4566785A (en) 1985-11-07
NZ197294A (en) 1984-12-14
CA1315041C (en) 1993-03-23
AU4566885A (en) 1985-11-07
PH21622A (en) 1987-12-11
NO166532C (no) 1991-08-07
IL72393A (en) 1985-06-30
IE811336L (en) 1981-12-17
PT73201A (en) 1981-07-01
US4298523A (en) 1981-11-03
EP0042291A2 (en) 1981-12-23
CA1188297A (en) 1985-06-04
EP0144103A2 (en) 1985-06-12
YU45852B (sh) 1992-09-07
NO166532B (no) 1991-04-29
EP0144103A3 (en) 1988-08-10
NO900294L (no) 1981-12-18
GR74546B (US06255285-20010703-C00102.png) 1984-06-29
AU4566685A (en) 1985-11-07
DK154653C (da) 1989-05-01
YU152881A (en) 1984-02-29
ES8304541A1 (es) 1983-03-01
EP0565148A3 (US06255285-20010703-C00102.png) 1994-02-09
FI811883L (fi) 1981-12-18
NO164245B (no) 1990-06-05
DK154437C (da) 1989-04-10
JPH01308297A (ja) 1989-12-12
ES8207513A1 (es) 1982-10-01
IE62614B1 (en) 1995-02-22
JPH01308298A (ja) 1989-12-12
NO161744B (no) 1989-06-12
IE62213B1 (en) 1995-01-11
IL63108A (en) 1985-06-30
IL72392A0 (en) 1984-11-30
ATE24183T1 (de) 1986-12-15
IL72392A (en) 1985-06-30
ES512721A0 (es) 1983-02-01
NO812035L (no) 1981-12-18
DK151968B (da) 1988-01-18
DE3175701D1 (en) 1987-01-22
DK415485A (da) 1985-09-12
PH16501A (en) 1983-11-04
ES512722A0 (es) 1983-03-01
DK227787A (da) 1987-05-04
IL72394A (en) 1985-06-30
CA1315042C (en) 1993-03-23
CA1282550C (en) 1991-04-02
DK151968C (da) 1988-09-19
NO164245C (no) 1990-09-12
NO161744C (no) 1989-09-20
DK263781A (da) 1981-12-18
NO885646L (no) 1981-12-18
FI79329B (fi) 1989-08-31
EP0042291B1 (en) 1986-12-10
IE940518L (en) 1981-12-17
JPS5728036A (en) 1982-02-15
JPH0357118B2 (US06255285-20010703-C00102.png) 1991-08-30
DE3177306T2 (de) 1994-06-30
EP0042291A3 (en) 1982-03-31
ES503012A0 (es) 1982-10-01
FI79329C (fi) 1989-12-11
IE881720L (en) 1981-12-17
EP0144103B1 (en) 1993-12-29
IL63108A0 (en) 1981-09-13
CA1285099C (en) 1991-06-18
DK154437B (da) 1988-11-14
ZA814061B (en) 1983-01-26
NO900294D0 (no) 1990-01-22
DK227787D0 (da) 1987-05-04
CA1315040C (en) 1993-03-23
EP0565148A2 (en) 1993-10-13
PT73201B (en) 1983-04-26
AU562808B2 (en) 1987-06-18
JPH0354957B2 (US06255285-20010703-C00102.png) 1991-08-21
AU563303B2 (en) 1987-07-02
JPH0355480B2 (US06255285-20010703-C00102.png) 1991-08-23
DE3177306D1 (de) 1994-02-10
ATE99327T1 (de) 1994-01-15
IL72393A0 (en) 1984-11-30
NO885646D0 (no) 1988-12-20
IL72394A0 (en) 1984-11-30
DK154653B (da) 1988-12-05

Similar Documents

Publication Publication Date Title
AU562807B2 (en) Tetrapeptides